Mulmit

Genprex, Inc.Genprex, Inc.

GNPX Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2024-12-310-21,174,167-21,388,282
2023-12-310-31,056,894-30,860,461
2022-12-310-23,830,719-23,740,621
2021-12-310-20,670,102-20,664,969
2020-12-310-17,961,581-17,942,770

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-04-14LONGNECKER BRENT M8
2026-04-14LONGNECKER BRENT M10
2026-02-27Berger Mark StanleyChief Medical Officer7,168
2026-02-27Confer Ryan M.President, CEO and CFO9,330
2025-12-22Moreno Toscano Jose Antonio9,000
2025-12-22Berger Mark StanleyChief Medical Officer28,500
2025-12-22Confer Ryan M.President, CEO and CFO45,000
2025-12-22LONGNECKER BRENT M9,000
2025-12-22Wilson William R Jr.9,000
2025-06-30Berger Mark StanleyChief Medical Officer4,500
2025-06-30Confer Ryan M.President, CEO and CFO5,775
2025-02-18Berger Mark StanleyChief Medical Officer585

8-K events

FiledItems
2026-08-18Other events · Financial statements and exhibits
2026-08-05Delisting or listing-standard notice · Financial statements and exhibits
2026-08-03Other events · Financial statements and exhibits
2026-07-30Delisting or listing-standard notice · Other events · Financial statements and exhibits
2026-07-14Material modification to rights of security holders · Amendments to charter or bylaws · Regulation FD disclosure · Other events · Financial statements and exhibits
2026-06-22Other events · Financial statements and exhibits
2026-06-18Officer or director change · Submission of matters to a vote · Financial statements and exhibits
2026-06-12Delisting or listing-standard notice · Other events · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…